< Arab Finance - News - Ibnsina Pharma logs EGP 104.99M profit in H1
Count Down to relaunch



Ibnsina Pharma logs EGP 104.99M profit in H1

Ibnsina Pharma logs EGP 104.99M profit in H1

ArabFinance: Ibnsina Pharma (ISPH) reported a consolidated net profit before minority interest of EGP 104.99 million in the first half (H1) of 2021, compared to profits of EGP 88.98 million in the corresponding period of 2020, according to the company’s financial statements filed to the Egyptian Exchange (EGX).

Net sales amounted to EGP 10.12 billion during the six-month period ended June 30th, up from EGP 8.87 billion in H1 2020.

Meanwhile, the company posted a standalone net profit of EGP 106.71 million in H1 2021, compared to profit of EGP 88.98 million in the prior-year period.

Ibnsina is an Egypt-based pharmaceutical distribution company. The company distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.

 

#Related keywords

'

Recommended Stocks

04 Oct 2021
United Housing & Development UNIT
Close
04.26
Change
01.19
Buy

All rights reserved to Arab Finance 2020 ©

Back to top